Hide Board Information

Show Board Information

Alcatel Lucent S.A. ALALF

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/05/2014 8:36:27 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Alcatel Lucent S.A. (OTCMRKTS: ALALF) Stock Message Board

1. ALALF Company Profile

    

2. ALALF Time & Sales

    

3. ALALF Recent News

    

4. ALALF Filings

    

5. ALALF Financials

    

6. ALALF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

3	ALALF 4.51 Stock Charts $ALALF 1 Month Chart	chartguy89	03/05/2014 8:36:27 PM
2	ALALF Stock Charts Saturday, February 22, 2014 at	chartguy89	02/22/2014 6:48:27 AM
1	ALALF Stock Chart 4.35 Saturday, February 8, 2014	chartguy89	02/08/2014 3:34:54 AM

Recent Articles

• Cheetah Net Supply Chain Reports Q3 2025 Financial Results
• Cheetah Net Supply Chain's Third Quarter Review and Insights
• NextGen Digital Secures Initial Funding Round with Major Placement
• What You Could Have Earned from Allstate: A 5-Year Review
• Understanding the Rise of Chronic Kidney Disease as a Global Challenge
• Trilogy Metals Initiates Major At-The-Market Equity Program
• Lennar Corporation Extends Exchange Offer Amid Market Uncertainties
• Exploring Parsons Corp's Growth: A Five-Year Journey
• GAP Sees Mixed Trends in Passenger Numbers Amid Challenges
• Vera Therapeutics Pioneers New Treatment for IgA Nephropathy
• Historic Infrastructure Agreement for Sustainable Ports Approved
• Your $100 Investment in Datadog: 5-Year Growth Insights
• Historic Agreement for Cleaner Air at Major Californian Ports
• Lennar Extends Exchange Offer Amid Ongoing Government Shutdown
• Mineralys Therapeutics' Innovations in Chronic Kidney Disease
• Beyond Meat Prepares for Q3 Financial Results and Updates
• Understanding the Inspire Medical Systems Securities Class Action
• The Growth of Modine Manufacturing: A Decade of Returns
• Exploring SLB's Growth: A $1,000 Investment Journey
• Join the Avantor Inc. Class Action Lawsuit and Secure Your Rights
• Investor Rights: Your Chance to Challenge MoonLake Immunotherapeutics
• Teva Pharmaceuticals Highlights Real-World Results for AUSTEDO
• Beyond Meat's Q3 2025 Results Announcement Plans Revealed
• Columbus A/S Share Transactions Report by Key Executives
• Rocket Doctor AI Inc. Issues RSUs and Stock Options to Staff
• HTCO Secures $3 Million Financing for Digital Advancements
• Investors Alert: Class Action Lawsuit Against Inspire Medical Systems
• Investors of Quanex Building Products Should Act Now to Secure Counsel
• Transformative Returns on Your United Rentals Investment
• HTCO Secures $3M Initial Financing for Digital Growth Initiatives
• California's Community Art Initiative Against Immigration Raids
• Cornerstone Funds Set Monthly Distributions for 2026
• Unlocking the Secrets of Multi-Million Dollar RV Park Investments
• Synopsys, Inc. Lawsuit Update: What Investors Need to Know
• Boston MedFlight's Agreement Enhances Care and Compensation
• Legacy Housing Corporation Shows Resilience Despite Challenges
• Crown Capital Partners Reveals Financial Insights from Q3 2025
• Taiga Building Products Ltd Reports Sales Growth in Q3
• Associated Capital Group's Stellar Q3 Performance Revealed
• Constellation Software Reports Impressive Q3 Financial Gains
• Avalon Holdings Corporation Shows Strong Q3 Financial Growth
• New Pacific Metals Corp Releases Q1 Financial Overview 2025
• Michael J. Fox Foundation's Podcast Receives Esteemed Honors
• WPP plc Investors Urged to Participate in Securities Class Action
• Replimune Highlights New Findings on RP1 in Cancer Therapy
• Discover Relief Mental Health's New Facility in Denver
• Investors of Marex Group plc Should Act Before Key Deadline
• Boehringer Ingelheim Unveils HERNEXEOS® for HER2 Lung Cancer
• Maxus Mining Secures Funding to Boost Exploration Initiatives
• America's Car-Mart Investors Get Support Amid Claims of Misleading Info